Ginkgo Biloba and Memory — A Research Summary
Ginkgo biloba has been used for cognitive enhancement for decades. Large, well-designed trials have found no significant benefit for preventing cognitive decline in healthy older adults.
How it might work
Ginkgo biloba extract (EGb 761) contains flavonoid glycosides and terpenoid lactones that have antioxidant, anti-inflammatory, and vasodilatory properties. It inhibits platelet-activating factor, potentially improving cerebral blood flow. Early small trials showed benefit in people with vascular dementia and age-related cognitive decline.
What the clinical trials show
The definitive evidence comes from two large, well-designed RCTs. The GEM (Ginkgo Evaluation of Memory) study (3,069 cognitively normal older adults, 6 years, 240mg EGb 761/day) published in JAMA in 2008 found no reduction in dementia incidence. The GuidAge trial (2,854 participants with memory complaints, 5 years, 240mg/day) found no significant reduction in Alzheimer's incidence.
A 2012 Cochrane review of 36 trials concluded that the evidence for ginkgo for dementia and cognitive decline is 'inconsistent and unreliable.' Some trials in people with existing dementia found modest symptomatic benefit.
Strength of evidence
Weak for prevention in cognitively normal people. The two largest and best-designed trials found no benefit. For people with existing MCI or dementia, some trials suggest modest symptomatic benefit, but the evidence remains inconsistent. The mechanism is plausible but insufficient to generate measurable clinical benefit at the doses studied.
Dosing used in research
The standard research dose is 240mg/day of standardized EGb 761 extract, divided into two doses. This is the same dose used in both large negative trials. Lower doses used in older small positive trials are less relevant given the later evidence.
Safety and considerations
Ginkgo has antiplatelet effects and should not be combined with warfarin, aspirin, or other blood thinners without medical supervision. Rare cases of seizure have been reported with high doses. The extract should be used rather than raw ginkgo leaf, which can contain allergenic compounds.
Our take
The evidence does not support ginkgo biloba as a cognitive health supplement for prevention in cognitively normal older adults. Two large, well-designed trials found no benefit. There are better-evidenced alternatives. If you currently take ginkgo and believe it helps, the mechanism plausibly supports some vasodilatory and antioxidant effects, but the clinical evidence for cognition specifically is not strong.
Frequently asked questions
Why did ginkgo fail in large trials when early studies were positive?
Early positive studies were small, often poorly designed, and sometimes conducted in people with existing cognitive impairment where vasodilatory effects might help more. The large prevention trials in cognitively normal older adults found no benefit. This pattern — small positive trials failing in large definitive ones — is common in supplement research.
Is ginkgo biloba safe?
At standard doses (240mg/day EGb 761), ginkgo is generally safe for most adults. The main concern is antiplatelet activity — it should not be combined with warfarin, aspirin, or other blood thinners without medical oversight. Discontinue before surgery.
Are there any cognitive supplements with stronger evidence than ginkgo?
Yes. For people with elevated homocysteine: B vitamins (VITACOG evidence). For people with low vitamin D: vitamin D supplementation. For people with MCI: lion's mane and alpha-GPC show more consistent positive trial evidence. And exercise remains the single best-evidenced intervention for cognitive protection.
Related resources
Start tracking your cognitive baseline
Four minutes a day. Five short tests. One trend line that builds over weeks and months so you can see where you stand — and separate a bad day from a real change.
Free to start. No account required. Not a diagnostic tool.